Lexel – Nestor Rava, CEO – Argentina
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Address: Escalada 1454, Buenos Aires (C1407LED),Argentina
Tel: (5411) 4670-3474
Web: http://www.dromex.com.ar/index_en.php
Dromex is a company founded on the basis of commitment and business loyalty between customers and suppliers in the Argentinian market. Dromex has over 25 years of experience in supplying active principles for the pharmaceutical industry, as well as a highly qualified, proactive and efficient professional work team to offer a high-class service.
Dromex’s main business is representing manufacturers of active principles for the Argentinean pharmaceutical industry. We represent first-class companies who work under the highest quality standards, recognized worldwide.
Having its own warehouse, authorized by the ANMAT (local regulatory agency), enables Dromex to keep the raw materials with the highest demand. Dromex can therefore offer a wide range of products and services to meet all the needs of any laboratory.
Dromex has a subsidiary in Brazil, Dromex Brasil, which carries out the same type of business in that market.
Warehousing, representing manufacturers
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview…
The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. Could you please…
The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines and becoming a pure pharmaceutical company. …
The general director of pharma in Argentina for the Bagó group explains why his group has planned that 75 percent of turnover will come from international markets in the coming years. 2014 marks…
The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this area, which is to have an impact on innovation at…
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
The general manager of Ferring Argentina believes that the country has one of the strongest social security systems in Latin America, with high reimbursement levels and coverage for most chronic…
The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in the region for Roche, and…
The general manager of Gennoma Laboratorios Argentina weighs up the factors of why raising brand awareness using public television is the key success to his company communication strategy. When…
“In the last decade, as a result of high and sustained growth, the Argentine pharmaceutical industry increased production by more than 240 percent, which speaks volumes about the capacity of…
The country president of AstraZeneca Argentina discusses the country’s patent laws, the work being done to bring innovation back to Argentina, and the challenge of a strong branded generics market…
See our Cookie Privacy Policy Here
